{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:02:00Z","timestamp":1762999320823,"version":"3.44.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01HL009610"],"award-info":[{"award-number":["R01HL009610"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.steroids.2017.11.015","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T08:42:36Z","timestamp":1513154556000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse"],"prefix":"10.1016","volume":"130","author":[{"given":"Adam M.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Chieh","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Turley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2017.11.015_b0005","series-title":"Cholesterol: Chemistry, Biochemistry, and Pathology","first-page":"145","article-title":"Distribution of sterols in organisms and in tissues","author":"Cook","year":"1958"},{"key":"10.1016\/j.steroids.2017.11.015_b0010","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.1965.45.4.747","article-title":"Cholesterol ester metabolism","volume":"45","author":"Goodman","year":"1965","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.steroids.2017.11.015_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0005-2760(69)90083-6","article-title":"Qualitative and quantitative estimation of free and esterified sterols in whole rat and in 23 of its tissues and organs","volume":"176","author":"D\u2019 Hollander","year":"1969","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.steroids.2017.11.015_b0025","series-title":"Physiology of the Gastrointestinal Tract","first-page":"1867","article-title":"Intestinal lipid absorption","author":"Tso","year":"1994"},{"key":"10.1016\/j.steroids.2017.11.015_b0030","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0022-2275(20)32360-9","article-title":"Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney and adrenal of nonhuman primates","volume":"41","author":"Lee","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1745-7270.2006.00154.x","article-title":"Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis","volume":"38","author":"Chang","year":"2006","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.steroids.2017.11.015_b0040","doi-asserted-by":"crossref","first-page":"26755","DOI":"10.1074\/jbc.273.41.26755","article-title":"ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization","volume":"273","author":"Cases","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2017.11.015_b0045","doi-asserted-by":"crossref","first-page":"28083","DOI":"10.1074\/jbc.M003927200","article-title":"Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine","volume":"275","author":"Chang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2017.11.015_b0050","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/01.CIR.0000143163.76212.0B","article-title":"ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver","volume":"110","author":"Parini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2017.11.015_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.0000166548.65753.1e","article-title":"ACAT2 is a target of coronary heart disease associated with hypercholesterolemia","volume":"25","author":"Rudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.steroids.2017.11.015_b0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11883-011-0171-6","article-title":"Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?","volume":"13","author":"Rousset","year":"2011","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.steroids.2017.11.015_b0065","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.1074\/jbc.272.11.7506","article-title":"Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency","volume":"272","author":"Sakai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2017.11.015_b0070","doi-asserted-by":"crossref","first-page":"15777","DOI":"10.1074\/jbc.272.25.15777","article-title":"Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type 1","volume":"272","author":"Ng","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2017.11.015_b0075","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0022-2275(20)31566-2","article-title":"ABCA1: the gatekeeper for eliminating excess tissue cholesterol","volume":"42","author":"Oram","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0080","unstructured":"G.A.Grabowski, H. Du, L. Chamas, Lysosomal Acid Lipase Deficiencies: The Wolman Disease\/Cholesteryl Ester Storage Disease Spectrum. http:\/\/ommbid.mhmedical.com\/content.aspx?bookid=474&sectionid=45374143, 2015 (accessed 02.06.15)."},{"key":"10.1016\/j.steroids.2017.11.015_b0085","series-title":"Zakim and Boyer\u2019s Hepatology: A Textbook of Liver Disease","first-page":"1155","article-title":"Inborn errors of metabolism that lead to permanent liver injury","author":"Ghishan","year":"2012"},{"key":"10.1016\/j.steroids.2017.11.015_b0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26327","article-title":"Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups","volume":"58","author":"Scott","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.steroids.2017.11.015_b0095","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.76.7.3330","article-title":"Receptor-mediated endocytosis: insights from the lipoprotein receptor system","volume":"76","author":"Brown","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.steroids.2017.11.015_b0100","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1194\/jlr.M700125-JLR200","article-title":"Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick disease","volume":"48","author":"Liu","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0105","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0022-2275(20)42344-2","article-title":"Lysosomal acid lipase deficiency in rats: lipid analyses and lipase activities in liver and spleen","volume":"31","author":"Kuriyama","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-2275(20)31157-3","article-title":"Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span","volume":"42","author":"Du","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0115","doi-asserted-by":"crossref","first-page":"G836","DOI":"10.1152\/ajpgi.00243.2014","article-title":"Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice","volume":"307","author":"Aqul","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.steroids.2017.11.015_b0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2014.04.006","article-title":"Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency disease","volume":"112","author":"Sun","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.steroids.2017.11.015_b0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2013.04.016","article-title":"Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance","volume":"59","author":"Thelwall","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.steroids.2017.11.015_b0130","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of Sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.steroids.2017.11.015_b0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/TACG.S86760","article-title":"Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa","volume":"9","author":"Su","year":"2016","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.steroids.2017.11.015_b0140","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0022-2275(20)34932-4","article-title":"Hepatic uptake of chylomicron remnants","volume":"38","author":"Cooper","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1194\/jlr.M018820","article-title":"Cholesterol esterification by ACAT2 is essential for efficient intestinal cholesterol absorption: evidence from thoracic lymph duct cannulation","volume":"53","author":"Nguyen","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0150","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbrc.2013.12.096","article-title":"Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease","volume":"443","author":"Chuang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.steroids.2017.11.015_b0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2014.10.063","article-title":"Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver","volume":"454","author":"Lopez","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.steroids.2017.11.015_b0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/jpet.115.227207","article-title":"PRD125, a potent and selective inhibitor of sterol O- acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice","volume":"355","author":"Lopez","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.steroids.2017.11.015_b0165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-2275(20)38333-4","article-title":"Studies on acyl-coenzyme A: cholesterol acyltransferase activity in human liver microsomes","volume":"30","author":"Einarrson","year":"1989","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0170","doi-asserted-by":"crossref","first-page":"G2012","DOI":"10.1152\/ajpgi.00190.2010","article-title":"Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1","volume":"299","author":"Turley","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.steroids.2017.11.015_b0175","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.20868","article-title":"Cholesterol accumulation and liver cell death in mice with Niemann-Pick Type C disease","volume":"42","author":"Beltroy","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.steroids.2017.11.015_b0180","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0022-2275(20)32171-4","article-title":"Marked reduction in bile acid synthesis in cholesterol 7\u03b1-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia","volume":"39","author":"Schwarz","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/advan.00019.2005","article-title":"The power of real-time PCR","volume":"29","author":"Valasek","year":"2005","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.steroids.2017.11.015_b0190","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/jn\/109.5.840","article-title":"Use of tritiated water for measurement of 24-hour milk intake in suckling lean and genetically obese (ob\/ob) mice","volume":"109","author":"Rath","year":"1979","journal-title":"J. Nutr."},{"key":"10.1016\/j.steroids.2017.11.015_b0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jn\/85.3.305","article-title":"Chemical characterization of inbred- strain mouse milk I. Gross composition and amino acid analysis","volume":"85","author":"Meier","year":"1965","journal-title":"J. Nutr."},{"key":"10.1016\/j.steroids.2017.11.015_b0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency \u2013 An under-recognized cause of dyslipidemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.steroids.2017.11.015_b0205","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00125-016-3968-6","article-title":"Lysosomal acid lipase regulates VLDL synthesis and insulin sensitivity in mice","volume":"59","author":"Radovi\u0107","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2017.11.015_b0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcp\/81.2.263","article-title":"Cholesterol ester storage disease and mesenteric lipodystrophy","volume":"81","author":"Dincsoy","year":"1984","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.steroids.2017.11.015_b0215","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1172\/JCI106997","article-title":"Enzyme deficiency in cholesteryl ester storage disease","volume":"51","author":"Sloan","year":"1972","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2017.11.015_b0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1258\/0004563001899195","article-title":"Accumulated lipids, aberrant fatty acid composition and defective cholesterol ester hydrolase activity in cholesterol ester storage disease","volume":"37","author":"Todoroki","year":"2000","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.steroids.2017.11.015_b0225","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1172\/JCI117760","article-title":"Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse","volume":"95","author":"Osono","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2017.11.015_b0230","series-title":"Physiology of the Gastrointestinal Tract","first-page":"145","article-title":"Proliferation and differentiation of gastrointestinal cells in normal and disease states","author":"Lipkin","year":"1981"},{"key":"10.1016\/j.steroids.2017.11.015_b0235","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1194\/jlr.M013789","article-title":"Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations","volume":"52","author":"Ramirez","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0240","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI9021","article-title":"Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase I","volume":"105","author":"Accad","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2017.11.015_b0245","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/82153","article-title":"Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice","volume":"6","author":"Buhman","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2017.11.015_b0250","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/CIRCRESAHA.115.304378","article-title":"Cholesterol esters (CE) derived from hepatic sterol O- acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2","volume":"115","author":"Zhang","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0255","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M000257","article-title":"Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid","volume":"51","author":"Liu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.steroids.2017.11.015_b0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.115.227348","article-title":"New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models","volume":"355","author":"Ohsiro","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.steroids.2017.11.015_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2213988501711010001","article-title":"Targeting Wolman disease and cholesteryl ester storage disease: disease pathogenesis and therapeutic development","volume":"11","author":"Aguisanda","year":"2017","journal-title":"Curr. Chem. Genom. Transl. Med."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1730226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1730226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:02:31Z","timestamp":1758535351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X1730226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":53,"alternative-id":["S0039128X1730226X"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2017.11.015","relation":{},"ISSN":["0039-128X"],"issn-type":[{"type":"print","value":"0039-128X"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2017.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}